Phenotypic analysis of mice bearing targeted deletions of 11β-hydroxysteroid dehydrogenases 1 and 2 genes
Authors:
- Yuri KotelevtsevYKYuri Kotelevtsev
- John J. MullinsJMJohn J. Mullins
- Jonathan R. SecklJSJonathan R. Seckl
- 1 January 2001
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 171 (1-2) , 15-20
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2Journal of Clinical Investigation, 1999
- 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stressProceedings of the National Academy of Sciences, 1997
- Cloning and production of antisera to human placental 11 β-hydroxysteroid dehydrogenase type 2Biochemical Journal, 1996
- Purification of 11 β-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling techniqueBiochemical Journal, 1996
- Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation.Genes & Development, 1995
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994
- Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene.Molecular and Cellular Biology, 1990
- Purification and Characterization of the Corticosteroid 1lβ-Dehydrogenase Component of the Rat Liver 1lβ-Hydroxysteroid Dehydrogenase Complex*Endocrinology, 1988
- Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, MediatedScience, 1988
- LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTORThe Lancet, 1988